RecruitingNot ApplicableNCT07138443

Influence of Melatonin on Cardiovascular and Thermoregulatory Responses to Stress

Influence of Melatonin on Cardiovascular and Skin Temperature Responses to Stress: A Randomized Controlled Trial


Sponsor

Baylor University

Enrollment

20 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the influence of acute oral melatonin supplementation on cardiovascular and skin temperature responses to mental stress. The hypothesis is that acute melatonin will lead to reduced cardiovascular and skin temperature responsiveness to acute mental stress.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Melatonin 3 MG Oral Tablet and Placebo Oral Tablet for people with mental stress and stress. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTMelatonin 3 MG Oral Tablet

Participants will ingest an acute 3mg oral melatonin tablet

DIETARY_SUPPLEMENTPlacebo Oral Tablet

Participants will ingest a placebo tablet (sugar pill) of the same size, shape, and color of the active melatonin supplement


Locations(1)

Baylor University Autonomic Function Laboratory

Waco, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07138443


Related Trials